Are economic evaluations and health technology assessments increasingly demanded in times of rationing health services? The case of the Argentine financial crisis

International Journal of Technology Assessment in Health Care

Volumn 23, Issue 2, 2007, Pages 169-176

  Rubinstein, Adolfo ^a,b   Belizán, María ^a   Discacciati, Vilda ^b  

^a INSTITUTE FOR CLINICAL EFFECTIVENESS AND HEALTH POLICY   (Argentina)

^b HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

Author keywords

Economic evaluation; Financial crisis in Argentina; Health technology assessment; Resource allocation

Indexed keywords

COST ACCOUNTING; DECISION MAKING; ECONOMIC ANALYSIS; ECONOMIC AND SOCIAL EFFECTS; FINANCE; RESOURCE ALLOCATION;

ALLOCATIVE EFFICIENCY; ECONOMIC EVALUATION; FINANCIAL CRISIS; HEALTH TECHNOLOGY ASSESSMENT;

HEALTH CARE;

ARGENTINA; ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; DOCTOR PATIENT RELATION; ECONOMIC ASPECT; HEALTH CARE FINANCING; HEALTH CARE NEED; HEALTH CARE POLICY; QUALITATIVE ANALYSIS; RESOURCE ALLOCATION; SEMI STRUCTURED INTERVIEW;

ARGENTINA; DECISION MAKING; ECONOMICS; FOCUS GROUPS; HEALTH CARE RATIONING; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTERVIEWS; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 34247378688     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S0266462307070274     Document Type: Article

References (13)

1. Costa J, Rovira J. A short practical guide to the focus group approach in analysing the role of economic evaluation on decision making in the health care system. J. Rovira, Personal communication. February, 1998.
2. Coyle D. Increasing the impact of economic evaluation on health care decision making. Discussion paper N 108. University of York: Center for Health Economics; 1993.
3. Drummond M, Cooke J, Walley T. Economic evaluation under managed competition: Evidence from the UK. Soc Sci Med. 1997;45:583-595.
4. Drummond M, Sculpher M, Torrance, G et al. Methods for the economic evaluation of health care programs. 3rd ed. New York: Oxford University Press; 2005.
5. Evans DE, Tan-Torres Edejer T, Adam T, Lim SL, for the WHO Choosing Interventions that are Cost Effective (CHOICE). Methods to assess the costs and health effects of interventions for improving health in developing countries. BMJ. 2005;331:1137-1140.
6. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJL, and the Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet. 2002;360:1347-1360.
7. Harris A, Buxton M, O'Brien B, Rutten F, Drummond M. Using economic evidence in reimbursement decision for health technologies: Experiences of 4 countries. Expert Rev Pharmacoeconomic Outcome Res. 2001;1:7-12.
8. Hoffmann C, Graf von der Schulenburg JM, on behalf of the Euromet group. The influence of economic evaluation studies on Decision making: a European Survey. Health Policy. 2000;52:179-192.
9. Hutubessy R, Chisholm D, Torres Edejer TT, and WHO CHOICE. Cost-effectiveness and resource allocation. Geneva: WHO; 2003;1:8.
10. Iglesias CP, Drummond MF, Rovira J, NEVALAT Project Group. Health-care decision-making processes in Latin America: problems and prospects for the use of economic evaluation. Int J Technol Assess Health Care. 2005;21:1-14.
11. Sloan FA, Whetten-Goldstein K, Wilson A. Hospital pharmacy decisions, cost-containment and their use of cost-effectiveness analysis. Soc Sci Med. 1997;45:525-533.
12. Taylor RS, Drummond MF, Salkeld G, Sullivan SD. Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle. BMJ. 2004;29:972-975.
13. Williams AH, Cookson RA. Equity-efficiency trade-offs in health technology assessment. Int J Technol Assess Health Care. 2006;22:1-9.